Showing results (41-50 of 211) with videos related to

Sort By:
Pageof 22
Current Hematologic Malignancy Reports|August 23, 2024
Prognostic and Predictive Models in MyelofibrosisBarbara Mora, Cristina Bucelli, Daniele Cattaneo, et al.
Leukemia Research Reports|August 11, 2017
An unusual type of myeloid sarcoma localization following myelofibrosis: A case report and literature reviewNicola Orofino, Daniele Cattaneo, Cristina Bucelli, et al.
European Journal of Haematology|April 4, 2017
Socioeconomic burden of participation in clinical trials in patients with myeloproliferative neoplasmsSwati Goel, Chiara Paoli, Alessandra Iurlo, et al.
British Journal of Haematology|July 29, 2022
Management of chronic myeloid leukaemia patients treated with ponatinib in a real-life setting: A retrospective analysis from the monitoring registries of the Italian Medicines Agency (AIFA)Massimo Breccia, Pier Paolo Olimpieri, Simone Celant, et al.
Oncotarget|July 13, 2014
Identification of kit(M541L) somatic mutation in chronic eosinophilic leukemia, not otherwise specified and its implication in low-dose imatinib responseAlessandra Iurlo, Umberto Gianelli, Alessandro Beghini, et al.
Human Mutation|July 22, 2009
Congenital dyserythropoietic anemia type II (CDAII) is caused by mutations in the SEC23B genePaola Bianchi, Elisa Fermo, Cristina Vercellati, et al.
Expert Opinion on Drug Safety|May 31, 2018
Intolerance to tyrosine kinase inhibitors in chronic myeloid leukemia: the possible role of ponatinibMassimo Breccia, Fabio Efficace, Alessandra Iurlo, et al.
Clinical and Experimental Medicine|July 23, 2024
Value and limitations of targeted next-generation sequencing in idiopathic hypereosinophilia: an integrative diagnostic tool in challenging casesDaniele Cattaneo, Alfredo Marchetti, Cristina Bucelli, et al.
Patient Preference and Adherence|November 7, 2022
Psychological Factors Affecting the Willingness to Accept a Possible Tyrosine Kinase Inhibitor (TKI) Discontinuation in Chronic Myeloid Leukaemia (CML) PatientsIlaria Cutica, Silvia Riva, Ester Maria Orlandi, et al.
Annals of Hematology|June 12, 2024
Red cell distribution width and prognosis in myelofibrosis patients treated with ruxolitinibDaniele Cattaneo, Nicole Galli, Cristina Bucelli, et al.
Pageof 22